Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein B is an essential structural component required for assembly/secretion/functionality of all major atherogenic plasma lipoproteins except HDL. Its measurement offers direct insight into cardiovascular risk beyond traditional cholesterol metrics due to its one-to-one correspondence with potentially pathogenic particle numbers.
Drugs targeting ApoB aim to reduce its levels or inhibit its function in assembling and transporting atherogenic lipoproteins, thereby reducing the risk of cardiovascular disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein B (ApoB).